Creative Biostructure Provides Various Vaccine Development Services for Coronavirus
Creative Biostructure, a leading contract service vendor in the field of structural biology, now supports the development of coronavirus vaccine more quickly and accurately with its virus-like particle platform.
Over the past five years, the world has experienced several viral outbreaks, including Ebola virus, Zika virus, MERS-CoV and SARS-CoV-2 (novel coronavirus, previously known as 2019-nCoV). Faced with the potential threat of a pandemic, research institutions and companies in multiple countries and regions around the world have announced vaccine development programs.
Only about 70 vaccines have been used to prevent 37 human infectious diseases and few have been successfully marketed. Among the vaccines approved for sale from 1880 to 2016, the vaccine development cycle takes 10 years, while some take more than 100 years. However, with the emergence and development of new vaccine R & D technology, the market release rate of vaccines has been gradually accelerated.
Over the past decade, Creative Biostructure has established state-of-the-art virus-like particle (VLP) platforms and provided satisfactory services for various VLP applications. Today, the company hopes to use this platform to support the development of coronavirus vaccines.
Creative Biostructure is committed to providing efficient and cutting-edge technical support for the development of vaccines for coronavirus diseases and other emerging infectious diseases, including but are not limited to the following types of vaccine development:
- Virus-like Particles Based Vaccine Development Services for Coronavirus
- Recombinant Subunit Vaccine Development Services for Coronavirus
- Recombinant Vector Vaccine Development Services for Coronavirus
- Nucleic Acid Vaccine Development Services for Coronavirus
“Our expertise and experience in custom VLP design/development and structure-based antiviral vaccine research makes us a reliable partner for your discovery of novel coronavirus vaccines. We guarantee customized and flexible services, professional management and regular communication, customer privacy and data security, and efficiency and cost-effectiveness.” Commented Joanna, the chief marketing staff at Creative Biostructure.
Moreover, Creative Biostructure provides protein structure determination for coronavirus research, protein interaction analysis services for coronavirus research, antiviral drug discovery services for coronavirus, bioinformatics analysis services for coronavirus research and coronavirus-like particle identification and characterization.
To know more about the vaccine development services for coronavirus provided by Creative Biostructure, please visit https://www.creative-biostructure.com/coronavirus/vaccine-development-services-for-coronavirus-p11.htm.